Vaš brskalnik ne omogoča JavaScript!
JavaScript je nujen za pravilno delovanje teh spletnih strani. Omogočite JavaScript ali pa uporabite sodobnejši brskalnik.
Nacionalni portal odprte znanosti
Odprta znanost
DiKUL
slv
|
eng
Iskanje
Brskanje
Novo v RUL
Kaj je RUL
V številkah
Pomoč
Prijava
NDMA formation due to active ingredient degradation and nitrite traces in drug product
ID
Golob, Nejc
(
Avtor
),
ID
Peterlin, Simona
(
Avtor
),
ID
Grahek, Rok
(
Avtor
),
ID
Roškar, Robert
(
Avtor
)
PDF - Predstavitvena datoteka,
prenos
(1,30 MB)
MD5: D268C6B83026B705F8EA90E0DE7E161E
URL - Izvorni URL, za dostop obiščite
https://www.sciencedirect.com/science/article/pii/S0022354923001077
Galerija slik
Izvleček
N-nitrosamines are genotoxic compounds which can be found as impurities in drug substances and drug products used in the pharmaceutical industry. To date, several possible nitrosamine sources in drug products have been reported and this study aims to illuminate another one. A case of afatinib drug product was investigated, in which up to 50 ppb N-nitrosodimethylamine (NDMA) traces were detected. Afatinib was found to degrade to the secondary amine dimethylamine (DMA), forming NDMA with traces of nitrite in crospovidone. Two series of film-coated tablets were prepared with crospovidone from two different manufacturers, containing different levels of nitrites. Tablets were subjected to an accelerated stability study (40 °C/75% relative humidity) or stored at room temperature and levels of NDMA, DMA and nitrite in tablets were monitored. NDMA and nitrite were found on ppb levels, whereas DMA was detected on ppm levels. NDMA formation in the drug product was found to be time, temperature and nitrite dependent and it was emphasized that DMA and nitrite should be reduced. The accelerated stability study proved to be a useful tool for predicting nitrosamine formation in the drug product.
Jezik:
Angleški jezik
Ključne besede:
N-nitrosodimethylamine
,
NDMA
,
afatinib drug product
,
drug substance degradation
,
dimethylamine
,
DMA
,
nitrite
,
excipient
,
crospovidone
,
stability study
Vrsta gradiva:
Članek v reviji
Tipologija:
1.01 - Izvirni znanstveni članek
Organizacija:
FFA - Fakulteta za farmacijo
Status publikacije:
Objavljeno
Različica publikacije:
Objavljena publikacija
Leto izida:
2023
Št. strani:
Str. 1277-1286
Številčenje:
Vol. 112, iss. 5
PID:
20.500.12556/RUL-148688
UDK:
661.12
ISSN pri članku:
0022-3549
DOI:
10.1016/j.xphs.2023.03.007
COBISS.SI-ID:
146220547
Datum objave v RUL:
29.08.2023
Število ogledov:
506
Število prenosov:
188
Metapodatki:
Citiraj gradivo
Navadno besedilo
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Kopiraj citat
Objavi na:
Gradivo je del revije
Naslov:
Journal of pharmaceutical sciences
Skrajšan naslov:
J. pharm. sci.
Založnik:
Elsevier, American Pharmacists Association
ISSN:
0022-3549
COBISS.SI-ID:
25777152
Licence
Licenca:
CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:
http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:
To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Sekundarni jezik
Jezik:
Slovenski jezik
Ključne besede:
N-nitrozodimetilamin
,
NDMA
,
zdravilo afatinib
,
razgradnja zdravilne učinkovine
,
dimetilamin
,
DMA
,
nitriti
,
pomožne snovi
,
krospovidon
,
stabilnostne študije
,
farmacevtska industrija
Podobna dela
Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:
Nazaj